EP1343501A4 - Therapie für neurologische infektionen mit dem herpes-virus unter verwendung von 1,4-dihydropyridin-kalziumantagonisten - Google Patents

Therapie für neurologische infektionen mit dem herpes-virus unter verwendung von 1,4-dihydropyridin-kalziumantagonisten

Info

Publication number
EP1343501A4
EP1343501A4 EP00987986A EP00987986A EP1343501A4 EP 1343501 A4 EP1343501 A4 EP 1343501A4 EP 00987986 A EP00987986 A EP 00987986A EP 00987986 A EP00987986 A EP 00987986A EP 1343501 A4 EP1343501 A4 EP 1343501A4
Authority
EP
European Patent Office
Prior art keywords
herpes
therapy
calcium channel
channel blockers
dihydropyridine calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00987986A
Other languages
English (en)
French (fr)
Other versions
EP1343501A1 (de
Inventor
Howard Zik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1343501A1 publication Critical patent/EP1343501A1/de
Publication of EP1343501A4 publication Critical patent/EP1343501A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
EP00987986A 2000-11-21 2000-11-21 Therapie für neurologische infektionen mit dem herpes-virus unter verwendung von 1,4-dihydropyridin-kalziumantagonisten Withdrawn EP1343501A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/031994 WO2002041893A1 (en) 2000-11-21 2000-11-21 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers

Publications (2)

Publication Number Publication Date
EP1343501A1 EP1343501A1 (de) 2003-09-17
EP1343501A4 true EP1343501A4 (de) 2004-12-15

Family

ID=21742018

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00987986A Withdrawn EP1343501A4 (de) 2000-11-21 2000-11-21 Therapie für neurologische infektionen mit dem herpes-virus unter verwendung von 1,4-dihydropyridin-kalziumantagonisten

Country Status (6)

Country Link
EP (1) EP1343501A4 (de)
JP (1) JP2004513965A (de)
CN (1) CN1479616A (de)
AU (1) AU2001224250A1 (de)
NO (1) NO20032276L (de)
WO (1) WO2002041893A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013526518A (ja) * 2010-05-13 2013-06-24 ザ ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション Ｍｃｉおよびアルツハイマー病の処置
WO2020163815A1 (en) * 2019-02-07 2020-08-13 Innomed Technologies, Inc. Ivig treatments for bell's palsy
CN109820852B (zh) * 2019-03-11 2021-02-19 中国农业科学院兰州兽医研究所 一种尼莫地平在制备预防口蹄疫病毒感染的药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039678A (en) * 1989-03-23 1991-08-13 Wake Forest University Method of increasing cranial vessel proliferation by administering nimodipine
WO1994014441A1 (en) * 1992-12-22 1994-07-07 Aktiebolaget Astra Use of an enantiomeric dihydropyridine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849412A (en) * 1986-06-05 1989-07-18 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections
US5677308A (en) * 1996-12-19 1997-10-14 Lerner; A. Martin Method for alleviating spasmodic torticollis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039678A (en) * 1989-03-23 1991-08-13 Wake Forest University Method of increasing cranial vessel proliferation by administering nimodipine
WO1994014441A1 (en) * 1992-12-22 1994-07-07 Aktiebolaget Astra Use of an enantiomeric dihydropyridine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LUITEN P G M ET AL: "Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca<2+> antagonist nimodipine, influence of aging and developmental drug treatment", NEURODEGENERATION, ACADEMIC PRESS LTD., LONDON, GB, vol. 4, no. 3, September 1995 (1995-09-01), pages 307 - 314, XP004552087, ISSN: 1055-8330 *
See also references of WO0241893A1 *

Also Published As

Publication number Publication date
CN1479616A (zh) 2004-03-03
WO2002041893A1 (en) 2002-05-30
NO20032276L (no) 2003-06-30
NO20032276D0 (no) 2003-05-20
EP1343501A1 (de) 2003-09-17
AU2001224250A1 (en) 2002-06-03
JP2004513965A (ja) 2004-05-13

Similar Documents

Publication Publication Date Title
SG85214A1 (en) Glass-ceramics
GB2366507B (en) Adjustable link assembly
AU7874500A (en) Purified attapulgite clay
IL159747A0 (en) Improved lottery system
GB0113027D0 (en) Safety headlights
SG86349A1 (en) Controller
EG23909A (en) Vatamin d, analogs
GB0030583D0 (en) Nerve regeneration
GB0212628D0 (en) A traction control system
GB0010161D0 (en) Novel phosphine compounds
GB2370713B (en) Television-set adjusting system
EP1343501A4 (de) Therapie für neurologische infektionen mit dem herpes-virus unter verwendung von 1,4-dihydropyridin-kalziumantagonisten
AU1603401A (en) Pyranoindoles for treating glaucoma
HUP0200842A3 (en) Combination preparation for treating malaria
GB2377209B (en) Wheel arch
GB2371543B (en) 3,3,5,5-Tetraalkyl-piperazin-2,6-dione stabilizers
GB2324284B (en) Traction means
GB0013490D0 (en) Novel monsanto process
GB0011240D0 (en) Novel phosphorous compounds
GB9904468D0 (en) Neurological disorders
GB0004017D0 (en) Abating snoring
GB9827414D0 (en) Surge-proof controller
AU137019S (en) Decorative arch
CA88613S (en) Traction stud
GB9910852D0 (en) Rap hii

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030623

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041104

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060531